From Nasdaq: 2025-06-02 06:32:00

Gerresheimer AG’s shares dropped 16% as the company slashed its first half and 2025 outlook due to weak demand in the cosmetics and oral liquid medications markets. The proposed dividend for 2024 will be reduced to 0.04 euros per share from 1.25 euros. Second quarter organic revenue growth is expected to be low single-digit with an adjusted EBITDA margin around 19%. Adjusted earnings per share for 2025 is projected to decline in the low double-digit percentage range. Gerresheimer anticipates organic revenue growth of 1 to 2 percent for the year. The company plans to release second-quarter results on July 10. Shares were trading at 53 euros on the XETRA.



Read more at Nasdaq: Gerresheimer Cuts Outlook, Proposed Dividend Due To Weak Demand; Stock Plunges